10:20 AM EDT, 05/18/2026 (MT Newswires) -- Hamlet BioPharma (HAMLET-B.ST) said Monday it secured new patents in Japan and India covering its family of drug candidates that kill cancer cells as well as technology linked to the treatment of bacterial infections.

The Swedish pharmaceutical company also obtained a further patent allowance in Japan. It has over 30 pending patent applications across countries.

Ämnen i artikeln

Hamlet BioPharma B

Senast

7,11

1 dag %

−0,56%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån